Markets:

Overview

News

Currencies

International

Treasuries

Integra LifeSciences Holdings Corporation - Common Stock (NQ:IART)

13.12 UNCHANGED

Streaming Delayed Price Updated: 1:00 PM EST, Nov 28, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Integra LifeSciences Holdings Corporation - Common Stock

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

KB Home, Bed Bath & Beyond And 3 Stocks To Watch Heading Into Wednesday ↗

January 11, 2023

With US stock futures trading mixed this morning on Wednesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

What 6 Analyst Ratings Have To Say About Integra Lifesciences ↗

December 12, 2022

Via Benzinga

Integra Lifesciences's Return On Capital Employed Overview ↗

October 28, 2022

Pulled from Benzinga Pro data, Integra Lifesciences (NASDAQ:IART) posted Q3 earnings of $49.91 million, an increase from Q2 of 11.45%. Sales dropped to $385.19 million, a 3.17% decrease between...

Via Benzinga

Integra LifeSciences Shares Surge On Q3 Beat ↗

October 26, 2022

Via Benzinga

Integra Lifesciences: Q3 Earnings Insights ↗

October 26, 2022

Integra Lifesciences (NASDAQ:IART) reported its Q3 earnings results on Wednesday, October 26, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

4 Analysts Have This to Say About Integra Lifesciences ↗

October 11, 2022

Over the past 3 months, 4 analysts have published their opinion on Integra Lifesciences (NASDAQ:IART) stock. These analysts are typically employed by large Wall Street banks and tasked with...

Via Benzinga

Integra LifeSciences Recalls CereLink Intracranial Pressure Monitors, Revises Guidance ↗

August 24, 2022

Via Benzinga

Piper Sandler Cuts Price Target For Integra Lifesciences As It Divests Wound Care Portfolio ↗

July 28, 2022

Via Benzinga

Integra LifeSciences Posts Street Beating Earnings, Backs FY22 Guidance ↗

April 27, 2022

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 12, 2022 ↗

October 12, 2022

Upgrades

Via Benzinga

Expert Ratings for Integra Lifesciences ↗

October 12, 2022

Within the last quarter, Integra Lifesciences (NASDAQ:IART) has observed the following analyst ratings:

Via Benzinga

Analyst Ratings for Integra Lifesciences ↗

October 11, 2022

Within the last quarter, Integra Lifesciences (NASDAQ:IART) has observed the following analyst ratings:

Via Benzinga

Integra Lifesciences's Return on Invested Capital Insights ↗

July 29, 2022

According to Benzinga Pro, during Q2, Integra Lifesciences (NASDAQ:IART) earned $44.79 million, a 36.13% increase from the preceding quarter. Integra Lifesciences also posted a total of $397.81 million...

Via Benzinga

Recap: Integra Lifesciences Q2 Earnings ↗

July 27, 2022

Integra Lifesciences (NASDAQ:IART) reported its Q2 earnings results on Wednesday, July 27, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For July 25, 2022 ↗

July 25, 2022

Upgrades

Via Benzinga

Looking Into Integra Lifesciences's Return On Capital Employed ↗

April 29, 2022

According to Benzinga Pro, during Q1, Integra Lifesciences (NASDAQ:IART) earned $32.90 million, a 27.51% increase from the preceding quarter. Integra Lifesciences's sales decreased to $376.64 million,...

Via Benzinga

Integra Lifesciences: Q1 Earnings Insights ↗

April 27, 2022

Integra Lifesciences (NASDAQ:IART) reported its Q1 earnings results on Wednesday, April 27, 2022 at 06:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

The Week Ahead In Biotech (April 24-April 30): Bristol-Myers Squibb, Supernus, Hutchmed, Axsome, Coherus FDA Decisions, Big Pharma Earnings, IPOs And More ↗

April 24, 2022

Biotech stocks extended their loses in the week ending April 22. The sector took cues from the broader market, which reacted to the lackluster start of the first-quarter reporting season and lingering...

Via Benzinga

Recap: Integra Lifesciences Q4 Earnings ↗

February 23, 2022

Integra Lifesciences (NASDAQ:IART) reported its Q4 earnings results on Wednesday, February 23, 2022 at 06:00 AM. Here's what investors need to know about the...

Via Benzinga

Price Over Earnings Overview: Integra Lifesciences ↗

January 18, 2022

Right now, Integra Lifesciences Inc. (NASDAQ:IART) share price is at $67.58, after a 1.75% decrease. Over the past month, the stock spiked by 1.91%, but over the past year...

Via Benzinga

A Peek Into The Markets: US Stock Futures Edge Higher Ahead Of Consumer Price Index ↗

January 12, 2022

Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Nasdaq jumped more than 200 points in the previous session. Investors are awaiting earnings...

Via Benzinga

Integra LifeSciences Reports Interim Q4 Sales Marginally Ahead Of Expectations ↗

January 12, 2022

Integra LifeSciences Holdings Corp (NASDAQ: IART) expects Q4 FY21 sales of $404 million - $406 million, representing an increase of approximately 4% Y/Y on a reported...

Via Benzinga

5 Stocks To Watch For January 12, 2022 ↗

January 12, 2022

Some of the stocks that may grab investor focus today are: Wall Street expects Shaw Communications Inc. (NYSE: SJR) to report quarterly earnings at $0.29 per share on revenue...

Via Benzinga

Here Are Answers for Shareholders After General Electric Breaks Up ↗

November 10, 2021

Larry Culp was hired to save GE in 2018, but finally decided to break it up in order to unlock what's left of its value, especially in the healthcare unit.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For December 17, 2021 ↗

December 17, 2021

Upgrades According to Morgan Stanley, the prior rating for Definitive Healthcare Corp (NASDAQ:

Via Benzinga

Integra LifeSciences Stock Rises On Street-Beating Q3 Earnings, Raises FY21 EPS Guidance ↗

November 02, 2021

Integra LifeSciences Holdings Corporation (NASDAQ: IART) shares got a boost as Q3 adjusted EPS of $0.86 topped the consensus forecast of $0.72. Revenues increased...

Via Benzinga

Integra LifeSciences Holdings Corporation (IART) Q3 2021 Earnings Call Transcript ↗

November 02, 2021

IART earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US ↗

November 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus SAB Spikes On Analyst Action SAB Biotherapeutics, Inc. (NASDAQ: SABS) shares...

Via Benzinga

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

5 Stocks Insiders Are Selling ↗

October 28, 2021

When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to...

Via Benzinga

< Previous 1 2

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Integra LifeSciences Holdings Corporation - Common Stock (NQ:IART)

All News about Integra LifeSciences Holdings Corporation - Common Stock

Starting at $3.75/week.

Subscribe Today